Two Sigma Advisers
GH icon

Two Sigma Advisers’s Guardant Health GH Stock Holding History

Two Sigma Advisers’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,382,300
Closed -$243M – 863
2025
Q4 		$243M Buy
2,382,300
+269,500
+13% +$24.1M 0.47% 45
2025
Q3 		$132M Sell
2,112,800
-269,000
-11% -$14.6M 0.26% 94
2025
Q2 		$124M Buy
2,381,800
+14,000
+0.6% +$625K 0.25% 89
2025
Q1 		$101M Buy
2,367,800
+52,200
+2% +$2.25M 0.23% 93
2024
Q4 		$70.7M Buy
2,315,600
+1,138,300
+97% +$32M 0.16% 125
2024
Q3 		$27M Buy
1,177,300
+406,500
+53% +$11.5M 0.06% 259
2024
Q2 		$22.3M Sell
770,800
-23,100
-3% -$538K 0.05% 308
2024
Q1 		$16.4M Sell
793,900
-13,400
-2% -$287K 0.04% 397
2023
Q4 		$21.8M Sell
807,300
-126,000
-14% -$3.31M 0.05% 309
2023
Q3 		$27.7M Buy
933,300
+187,100
+25% +$6.58M 0.07% 233
2023
Q2 		$26.7M Buy
746,200
+359,200
+93% +$10.3M 0.07% 259
2023
Q1 		$9.07M Buy
387,000
+210,700
+120% +$6.02M 0.02% 584
2022
Q4 		$4.8M Buy
176,300
+122,800
+230% +$5.62M 0.01% 798
2022
Q3 		$2.88M Buy
53,500
+22,800
+74% +$1.17M 0.01% 994
2022
Q2 		$1.24M Buy
+30,700
New +$1.52M ﹤0.01% 1475
2021
Q3 		– Sell
-1,700
Closed -$211K – 2517
2021
Q2 		$211K Sell
1,700
-24,300
-93% -$3.27M ﹤0.01% 2255
2021
Q1 		$3.97M Buy
+26,000
New +$3.93M 0.01% 948

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers's GH Position: Q1 2026 in Review

Two Sigma Advisers sold out of Guardant Health (GH) in Q1 2026, closing a stake of 2,382,300 shares — an estimated $243M sold.

Two Sigma Advisers first reported a position in GH in Q1 2021 and held it in 17 quarters. The position peaked at $243M in Q4 2025. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Two Sigma Advisers reported no remaining Guardant Health position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 2,382,300 Guardant Health shares in Q1 2026, an estimated $243M.
  • Two Sigma Advisers first reported a position in Guardant Health in Q1 2021 and held it in 17 quarters.
  • Two Sigma Advisers's Guardant Health position peaked at $243M in Q4 2025.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.